▲ Peaking
Health
BMI alternative would flip obesity diagnosis for millions, study finds
New research suggests body mass index may have misclassified millions of people, sparking discussions about health measurements.
Obesity
85 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Business
Pfizer Signs $1.5 Billion Deal With Blackstone to Fund Weight-Loss-Drug Development
Pfizer secures up to $1.5 billion from Blackstone Life Sciences to advance a once-monthly GLP-1 obesity treatment acquired from Metsera.
↑ Rising
Health
Validation of clinical and preclinical obesity across global cohorts
A proposed new obesity definition could reclassify millions of people worldwide, shifting diagnosis beyond body mass index alone.
↑ Rising
Business
Column | Powerful new weight-loss drug may also ease knee pain, major study finds
Eli Lilly's Zepbound shows promise for knee pain relief alongside weight loss in new Phase 3b data, while Taltz combination therapy demonstrates durable psoriatic arthritis outcomes.
▲ Peaking
Health
Move over BMI: new obesity definition is better for predicting your health
A new obesity definition validated across global cohorts could replace BMI and prevent misdiagnosis in millions, according to studies published in Nature and covered by major outlets.
▲ Peaking
Health
6-minute daily habit could help Ozempic users preserve muscle, expert says
A 40-week study found that resistance training helped people taking tirzepatide lose 25% less lean tissue while improving strength by 10%.
◼ Archived
Business
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
◼ Archived
Health
Obesity drugs may help protect memory and cognitive abilities - News-Medical
A major review of nearly 200 preclinical studies and major clinical trials finds that GLP-1 obesity drugs may protect the brain, but randomized trials have not shown a clear cognitive benefit.
◼ Archived
Health
Scientists invent implant that can transform sugar in the blood to treat type 2 diabetes
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Science
Scientists discover a hidden switch that burns fat and blocks new fat cells
4 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Women On GLP-1s Are Revealing The Side Effects And Experiences No One Told Them About
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
The Most Powerful Obesity Drug Yet Has a Hidden Benefit—and It Happens While You Sleep
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Triple-action weekly weight-loss drug reduces sleep apnea in two late-stage trials
An investigational triple-action weekly weight-loss drug significantly reduces obstructive sleep apnea severity in late-stage clinical trials.
◼ Archived
Health
Vegan-fed cats less often reported overweight in survey
Recent research reveals that cats fed vegan diets are less often reported as overweight compared to others.
◼ Archived
Health
Can GLP-1s heal the brain? Obesity drugs get a makeover for addiction and depression
Obesity drugs face a major pivot as clinical trials investigate their potential to treat addiction, depression, and criminal behavior.
◼ Archived
Business
Roche inks $1.2B deal with China's Rona to enter emerging ALK7 obesity race
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
World
Experts Identified The Gravest Health Threats Facing Humanity
Researchers identify seventeen major global health threats, highlighting obesity, nuclear war, and artificial intelligence.
◼ Archived
Health
What parents should know about GLP-1s for kids
Recent coverage examines the rising use of GLP-1 medications among children, highlighting strong weight loss alongside nutritional and data gaps.
◼ Archived
Health
People With Dementia May Actually Live Longer if They Carry Extra Weight
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Nagging people to eat healthily does not work
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
New weight-loss drug could give you a ‘flatter stomach’ in mere weeks
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Obesity’s Epigenetic ‘Memory’ Fuels Weight Regain
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Scientists uncover a clue that could hint at why we regain weight after diets
Recent scientific findings reveal a molecular clue regarding why individuals often regain weight after dieting or stopping medications.
◼ Archived
Health
Time-restricted eating boosts weight loss in adults with obesity, prediabetes
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
The Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What Kind
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Lilly sets up next-gen obesity battle with full phase 3 retatrutide data
Lilly positions its retatrutide drug combo for a next-generation obesity battle following full phase 3 study results.
◼ Archived
Business
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Eli Lilly reports that its new combination obesity regimen, EloraTZP, outperformed tirzepatide in a mid-stage clinical trial.
◼ Archived
Business
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Eli Lilly's experimental triple agonist drug retatrutide demonstrates significant weight loss and A1C reduction in recent clinical trials.
◼ Archived
Health
Zepbound Is Known for Weight Loss, but Scientists Just Found Something Unexpected
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'
GLP-1 medications are shifting from clinical obesity treatments for patients to lifestyle products for customers, amid a surge in oral pill options.
◼ Archived
Business
Novo Nordisk to Pay Up to $1.3 Billion for Nanexa’s Drug Delivery Technology
Novo Nordisk strikes a $1.3 billion deal with Nanexa to secure long-acting obesity injection technology.
◼ Archived
Health
GLP-1 drugs fail to help some people lose weight
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
New research indicates nearly 17% of children using GLP-1 receptor agonists developed nutritional deficiencies within one year of treatment.
◼ Archived
Business
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
18 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Millions of parents are taking GLP-1s. How should they talk to their kids about it?
As GLP-1 use rises among millions of parents and an increasing number of children, new medical data warns of nutritional risks for youth.
◼ Archived
Health
When Weight Loss Isn’t the Goal of Taking a GLP-1
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Can Obesity Treatment With GLP-1 Drugs Last Forever?
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
What Really Disappears When You Lose Weight on GLP-1 Drugs?
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
No more Nordisk as Novo goes it alone amid rebranding push
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement
Endocrine Society scientific statement shifts obesity treatment focus beyond weight loss to broader health goals.
◼ Archived
Health
🔮 fades ✓
GLP-1 prescriptions for kids up more than 30,000% since 2019
Prescriptions for GLP-1 medications among children in the United States have surged by over 30,000% since 2019.
◼ Archived
Business
🔮 fades ✓
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Novo Nordisk faces a divergent clinical outlook as its pediatric obesity trials succeed while heart drug programs for CKD suffer setbacks.
◼ Archived
Business
🔮 fades ✗
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
Novo Nordisk's Wegovy shows weight-loss results in young children during trial data releases.
◼ Archived
Business
🔮 fades ✗
Novo scraps two more heart drug trials, further dimming growth beyond obesity
Novo Nordisk faces a diverging trajectory as it meets pediatric obesity goals but terminates two heart disease drug trials.
◼ Archived
Health
🔮 fades ✗
Is keto better for your liver? New study find a potential advantage
Recent studies indicate that very low-carbohydrate diets may offer distinct liver and cardiometabolic advantages.
◼ Archived
Health
🔮 fades ✗
'Microdosing' GLP-1s can shed pounds, but here are the dangers
Concerns grow over the 'microdosing' of GLP-1 weight-loss medications as reports emerge regarding their effectiveness at low doses and long-term maintenance.
◼ Archived
Health
🔮 fades ✗
Experts call for safer weight loss as concerns grow over GLP-1 use - News-Medical
Experts call for safer weight loss methods as public and medical attention intensifies around the use and effectiveness of GLP-1 medications.
◼ Archived
Health
🔮 fades ✓
I lost the weight on a GLP-1
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Experimental Drug Makes Obese Mice Burn Fat Without Losing Muscle
Researchers have discovered that an old small molecule drug may enable the burning of fat while preserving lean muscle in obese mice.
◼ Archived
Health
🔮 fades ✓
Is the US seeing a turning point in obesity rates?
Medical experts and researchers are analyzing whether the rise of GLP-1 drugs signals a turning point for obesity rates in the United States.
◼ Archived
Health
🔮 fades ✗
New weight loss drug may burn fat without muscle loss seen in GLP-1 drugs
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Wegovy and Zepbound are changing how Americans get health care
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Could GLP-1s help with alcohol use disorder? A Philly VA doctor is leading a national trial to find out.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Why Three Minutes Of Sprinting May Beat An Hour+ Spent Exercising
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
There's One Genetic Variant That Makes The Body Burn Fat Instead of Storing It
A million-person genetic study identifies a protective metabolic variant that shifts the body toward burning fat.
◼ Archived
Health
🔮 fades ✓
Supercharged by Social Media, the GLP-1 Boom Is Warping Teen Psyches
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
GLP-1 use tied to obesity decline, but doctors warn of alarming misuse
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.